• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Harrow Closes Acquisition of U.S. Rights to ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE

    BUSINESSWIRE

    Novartis, busy with its restructuring, sells 5 eye drugs for up to $175M

    FIERCEPHARMA

    Imprimis NJOF, LLC Receives FDA Warning Letter

    FDA

    Mati Therapeutics PhII Nepafenac Evolute® Trial Results Show Significant Post

    BUSINESSWIRE

    Mati Therapeutics PhII Results Signal Significant Post-op Pain Reduction

    BUSINESSWIRE

    Prescription med: new or extended uses, new combinations of registered medicines

    TGA

    Imprimis Pharmaceuticals Receives FDA Warning Letter

    FDA

    Imprimis Pharmaceuticals Announces Plans to Launch IV Free™ Conscious Sedation

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.